Clinical trial
Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation: a Multicenter Randomized Controlled Trial
NCT03769441 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation: a Multicenter Randomized Controlled Trial
- Lead sponsor
- University Medical Center Groningen
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 2, 2019
- Completion date
- August 19, 2024
- Enrollment
- 148 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
iron-deficiency, transplant-related disorder